These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15155244)

  • 1. Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model.
    Iyer RP; Roland A; Jin Y; Mounir S; Korba B; Julander JG; Morrey JD
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2318-20. PubMed ID: 15155244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
    Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
    Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of hepatitis B virus (HBV) replication using antisense LNA targeting to both S and C genes in HBV].
    Deng YB; Nong LG; Huang W; Pang GG; Wang YF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):900-4. PubMed ID: 20038330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B.
    Cheng PN; Tsai HW; Chiu YC; Ho CH; Wu IC; Chang TT
    J Clin Virol; 2013 Aug; 57(4):323-30. PubMed ID: 23731848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiviral effects of dual-target antisense LNA by cationic liposomes in transgenic mice].
    Deng Y; Nong L; Wei Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):828-32, 837. PubMed ID: 24059065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiviral effects of dual-target antisense rna: an experimental study with hepatitis B virus transgenic mice].
    Zhao W; Chen H; Peng ZY; Li WG; Xi HL; Xu XY
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3486-90. PubMed ID: 16686065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
    Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
    Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus.
    Julander JG; Colonno RJ; Sidwell RW; Morrey JD
    Antiviral Res; 2003 Aug; 59(3):155-61. PubMed ID: 12927305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice.
    Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y
    Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy.
    Chen J; Wang Z; Zhou B; Wang Y; Hou J
    Antivir Ther; 2012; 17(1):71-9. PubMed ID: 22267471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
    Marcellin P; Heathcote EJ; Buti M; Gane E; de Man RA; Krastev Z; Germanidis G; Lee SS; Flisiak R; Kaita K; Manns M; Kotzev I; Tchernev K; Buggisch P; Weilert F; Kurdas OO; Shiffman ML; Trinh H; Washington MK; Sorbel J; Anderson J; Snow-Lampart A; Mondou E; Quinn J; Rousseau F
    N Engl J Med; 2008 Dec; 359(23):2442-55. PubMed ID: 19052126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
    Demirören K; Kocamaz H; Doğan Y
    Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse: application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy.
    Kajino K; Kamiya N; Yuasa S; Takahara T; Sakurai J; Yamamura Ki; Hino O
    Biochem Biophys Res Commun; 1997 Dec; 241(1):43-8. PubMed ID: 9405231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression.
    Chu X; Wu B; Fan H; Hou J; Hao J; Hu J; Wang B; Liu G; Li C; Meng S
    Antiviral Res; 2016 Mar; 127():41-9. PubMed ID: 26784393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B.
    Lee JM; Park JY; Kim DY; Nguyen T; Hong SP; Kim SO; Chon CY; Han KH; Ahn SH
    Antivir Ther; 2010; 15(2):235-41. PubMed ID: 20386079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis gene chip in detecting HBV DNA, HCV RNA in serum and liver tissue samples of hepatitis patients.
    Zhao W; Wan JM; Liu W; Liu QJ; Zhang L; Zhou ZX; Liu XJ; Zhang HR
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):234-41. PubMed ID: 14599976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.
    Marcellin P; Chang TT; Lim SG; Tong MJ; Sievert W; Shiffman ML; Jeffers L; Goodman Z; Wulfsohn MS; Xiong S; Fry J; Brosgart CL;
    N Engl J Med; 2003 Feb; 348(9):808-16. PubMed ID: 12606735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.